HDAC3 and Alzheimer disease: Moreover, we found increased HDAC3 levels, concomitantly with diminished H3 acetylation, in postmortem cortex of AD patients at Braak stages III–IV, which was associated with CDR of 0.5 and very mild dementia (Therriault et al., 2022).